These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20888323)

  • 1. Dopamine D2 and 5-hydroxytryptamine 5-HT(₂A) receptors assemble into functionally interacting heteromers.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Marcellino D; Ciruela F; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2010 Oct; 401(4):605-10. PubMed ID: 20888323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization.
    Borroto-Escuela DO; Narvaez M; Marcellino D; Parrado C; Narvaez JA; Tarakanov AO; Agnati LF; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):767-72. PubMed ID: 20171159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
    Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor.
    Łukasiewicz S; Faron-Górecka A; Kędracka-Krok S; Dziedzicka-Wasylewska M
    Eur J Pharmacol; 2011 Jun; 659(2-3):114-23. PubMed ID: 21496455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Gómez-Soler M; Corrales F; Marcellino D; Narvaez M; Frankowska M; Flajolet M; Heintz N; Agnati LF; Ciruela F; Fuxe K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):801-7. PubMed ID: 21040702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.
    Fuxe K; Marcellino D; Rivera A; Diaz-Cabiale Z; Filip M; Gago B; Roberts DC; Langel U; Genedani S; Ferraro L; de la Calle A; Narvaez J; Tanganelli S; Woods A; Agnati LF
    Brain Res Rev; 2008 Aug; 58(2):415-52. PubMed ID: 18222544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
    Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
    Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration.
    Borroto-Escuela DO; Tarakanov AO; Guidolin D; Ciruela F; Agnati LF; Fuxe K
    IUBMB Life; 2011 Jul; 63(7):463-72. PubMed ID: 21698749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization.
    Łukasiewicz S; Faron-Górecka A; Dobrucki J; Polit A; Dziedzicka-Wasylewska M
    FEBS J; 2009 Feb; 276(3):760-75. PubMed ID: 19143836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis.
    Fuxe K; Marcellino D; Leo G; Agnati LF
    Curr Opin Pharmacol; 2010 Feb; 10(1):14-22. PubMed ID: 19942481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R.
    Borroto-Escuela DO; Marcellino D; Narvaez M; Flajolet M; Heintz N; Agnati L; Ciruela F; Fuxe K
    Biochem Biophys Res Commun; 2010 Mar; 394(1):222-7. PubMed ID: 20197060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors.
    Lukasiewicz S; Polit A; Kędracka-Krok S; Wędzony K; Maćkowiak M; Dziedzicka-Wasylewska M
    Biochim Biophys Acta; 2010 Dec; 1803(12):1347-58. PubMed ID: 20831885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
    J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.
    Albizu L; Holloway T; González-Maeso J; Sealfon SC
    Neuropharmacology; 2011 Sep; 61(4):770-7. PubMed ID: 21645528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of functional roles of DRY motif in the 2nd intracellular loop of dopamine D2 and D3 receptors.
    Kim JH; Cho EY; Min C; Park JH; Kim KM
    Arch Pharm Res; 2008 Apr; 31(4):474-81. PubMed ID: 18449505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.